MBX Biosciences, Inc. (MBX) vs uniQure N.V. (QURE)
MBX Biosciences, Inc. and uniQure N.V. are both Biotechnology companies. MBX Biosciences, Inc. and uniQure N.V. are of similar size ($2.7B and $2.7B). MBX Biosciences, Inc. has the higher net margin (0.00% vs −1,350.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, MBX Biosciences, Inc. leads on 11 and uniQure N.V. on 1.
Valuation
Profitability
| Metric | MBX | QURE | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 92.49% | 65.16% |
| Operating margin | 0.00% | (1,071.53%) | 0.00% |
| Net margin | 0.00% | (1,350.73%) | 0.00% |
| Free cash flow margin | 0.00% | (864.67%) | 0.00% |
| Return on equity | (33.17%) | (157.61%) | (57.72%) |
| Return on assets | (31.25%) | (32.13%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack